GlaucomaCME

This activity is expired and is no longer available for CME credit.

LECTURECME

Advances in Medical Therapy for Glaucoma: New Solutions for a Pressing Problem

Author(s)/Faculty: Thomas W. Samuelson, MD; Louis R. Pasquale, MD; Inder Paul Singh, MD
Release Date: 2/2/2018Expiration Date: 2/1/2019
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have facilitated earlier glaucoma diagnosis and subsequent timely initiation of therapy, potentially reducing irreversible blindness as well as loss of quality of life. However, many patients with glaucoma remain at risk for disease progression due to inadequate control of intraocular pressure (IOP), which may be related to inadequacy of current therapy options or lack of adherence to treatment regimens that consist of multiple therapies. Therapies for glaucoma either increase outflow or decrease production of aqueous humor to reduce IOP, but IOP must be tightly controlled to provide optimal patient outcomes. In this activity, experts in the field will review and evaluate the latest clinical evidence for the safety and efficacy of current, new, and emerging classes of therapy, as well as discuss their mechanisms of action, and provide clinical insights into the effective management of IOP with presentation of patient case studies.